• Weak-affinity Chromatography Screening

    • Fragment-based Hit Generation

    • Structure-based Drug Design

    • In Silico Lead Discovery

Integrated Drug Discovery Services

SARomics Biostructures’ integrated drug discovery platform, which is run in close cooperation with Red Glead Discovery, combines key capabilities from a number of disciplines:

• Weak Affinity Chromatography (
• Nuclear Magnetic Resonance spectroscopy (NMR)
• Thermal Shift Assay (DSF)
• X-ray Crystallography
Computational chemistry
• Microscale Thermophoresis (MST)
• Biochemical & cell-based screening

Our fragment-based hit identification, lead generation and structure-based lead optimization platform in combination with state of the art
structural biology platform allow us to offer a variety of drug discovery service packages.